1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Deep Brain Stimulators (DBS) Overview
3 Products under Development
3.1 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
3.2 Deep Brain Stimulators (DBS) - Pipeline Products by Territory
3.3 Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
3.4 Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
3.5 Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
4 Deep Brain Stimulators (DBS) - Pipeline Products under Development by Companies
4.1 Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
4.2 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
5 Deep Brain Stimulators (DBS) Companies and Product Overview
5.1 Adaptive Neuromodulation GmbH Company Overview
5.2 Adept Neuro SA Company Overview
5.3 Aleva Neurotherapeutics SA Company Overview
5.4 Baylor College of Medicine Company Overview
5.5 Bioinduction Limited Company Overview
5.6 Boston Scientific Corp Company Overview
5.7 Brainsway Ltd Company Overview
5.8 Cleveland Medical Devices Inc Company Overview
5.9 Clinatec Company Overview
5.10 Deep Brain Innovations, LLC Company Overview
5.11 Enspire DBS Therapy Inc Company Overview
5.12 Functional Neuromodulation Inc. Company Overview
5.13 Louisiana State University Company Overview
5.14 Massachusetts General Hospital Company Overview
5.15 Massachusetts Institute of Technology Company Overview
5.16 Medtronic Plc Company Overview
5.17 National Cheng-Kung University Hospital Company Overview
5.18 NeuroOne Inc Company Overview
5.19 Neuroparticle Corp Company Overview
5.20 NeuroPro Technologies Inc Company Overview
5.21 Neurosigma Inc Company Overview
5.22 Newronika s.r.l. Company Overview
5.23 Nexeon MedSystems Inc Company Overview
5.24 Nia Therapeutics Inc Company Overview
5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.26 St. Jude Medical LLC Company Overview
5.27 Sunnybrook Health Sciences Centre Company Overview
5.28 SUNY Downstate Medical Center Company Overview
5.29 University of California Los Angeles Company Overview
5.30 University of Central Florida Company Overview
5.31 University of Florida Company Overview
5.32 University of Houston Company Overview
5.33 University of Illinois Company Overview
5.34 University of Milan Company Overview
5.35 University of Oxford Company Overview
5.36 University of Rochester Company Overview
5.37 University of South Florida Company Overview
5.38 Wedge Therapeutics Company Overview
6 Deep Brain Stimulators (DBS)- Recent Developments
6.1 Sep 10, 2020: TMS Clinics of Canada opens new facility to offer deep Transcranial Magnetic Stimulation (Deep TMS) for patients With Major Depressive Disorder (MDD)
6.2 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
6.3 Feb 26, 2020: Mayo Clinic reports 'remarkable growth' in 2019
6.4 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
6.5 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
6.6 Feb 18, 2020: Medtronic reports third quarter financial results 2020
6.7 Feb 10, 2020: BrainsWay appoints Avner Lushi to Join Board of Directors
6.8 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
6.9 Jan 27, 2020: Abbott secures expanded FDA approval for Infinity DBS System
6.10 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
6.11 Jan 09, 2020: Medtronic receives CE Mark approval for the Percept PC Neurostimulator DBS System with BrainSense Technology
6.12 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health
6.13 Dec 17, 2019: Aleva Neurotherapeutics gets CE Mark for brain stimulation system
6.14 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
6.15 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform
6.16 Dec 02, 2019: BrainsWay announces successful results in pivotal multicenter study evaluating deep Transcranial Magnetic Stimulation System as an aid in smoking cessation
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer
List of Tables
Table 1: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Table 2: Deep Brain Stimulators (DBS) - Pipeline Products by Territory
Table 3: Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
Table 4: Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
Table 5: Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
Table 6: Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
Table 7: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Table 8: Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 9: CR-Capable Implant - Product Status
Table 10: CR-Capable Implant - Product Description
Table 11: Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Stereo-Electro-Encephalo-Graphie Electrode - Product Status
Table 13: Stereo-Electro-Encephalo-Graphie Electrode - Product Description
Table 14: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
Table 15: directSTIM - Product Status
Table 16: directSTIM - Product Description
Table 17: Aleva Neurotherapeutics SA - Ongoing Clinical Trials Overview
Table 18: directSTIM - A Prospective, Multi-center, Post-market Clinical Follow-up Study of the directSTIM Deep Brain Stimulation (DBS) System
Table 19: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Adaptive Deep Brain Stimulation (aDBS) Device - Product Status
Table 21: Adaptive Deep Brain Stimulation (aDBS) Device - Product Description
Table 22: Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Picostim - Product Status
Table 24: Picostim - Product Description
Table 25: Bioinduction Limited - Ongoing Clinical Trials Overview
Table 26: Picostim - Simpler and Safer Deep Brain Stimulation for Parkinson's Disease
Table 27: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Enspire DBS Therapy System - Traumatic Brain Injury - Product Status
Table 29: Enspire DBS Therapy System - Traumatic Brain Injury - Product Description
Table 30: Next Generation DBS System - Product Status
Table 31: Next Generation DBS System - Product Description
Table 32: Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Deep TMS System - Alzheimer's Disease - Product Status
Table 34: Deep TMS System - Alzheimer's Disease - Product Description
Table 35: Deep TMS System - Bipolar Disorder - Product Status
Table 36: Deep TMS System - Bipolar Disorder - Product Description
Table 37: Deep TMS System - Multiple Sclerosis - Product Status
Table 38: Deep TMS System - Multiple Sclerosis - Product Description
Table 39: Deep TMS System - Post-Stroke - Product Status
Table 40: Deep TMS System - Post-Stroke - Product Description
Table 41: Deep TMS System - PTSD - Product Status
Table 42: Deep TMS System - PTSD - Product Description
Table 43: Deep TMS System - Smoking Cessation - Product Status
Table 44: Deep TMS System - Smoking Cessation - Product Description
Table 45: Deep Transcrainal Magnetic Stimulation Device - Opioid Use Disorder - Product Status
Table 46: Deep Transcrainal Magnetic Stimulation Device - Opioid Use Disorder - Product Description
Table 47: Next-Generation Multi-Channel TMS Stimulator - Product Status
Table 48: Next-Generation Multi-Channel TMS Stimulator - Product Description
Table 49: Brainsway Ltd - Ongoing Clinical Trials Overview
Table 50: Deep TMS System - Bipolar Disorder - A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation (TMS) in Conjunction with Mood Stabilizers in Subjects with Bipolar Depression
List of Figures
Figure 1: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Figure 2: Deep Brain Stimulators (DBS) - Pipeline Products by Territory
Figure 3: Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
Figure 4: Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
Figure 5: Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
